INDP
Indaptus Therapeutics, Inc.Company Information
- Company Name
- Indaptus Therapeutics, Inc.
- CIK
- CIK0001857044
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- INDP: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- INDP
SEC filing data through
Insider Sentiment
- Last purchase
- 2023-08-14
- Last sale
- 2022-02-01
- Shares purchased (TTM)
- 53,124
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 179,123
- Shares outstanding
- 116,131,213
- Ownership
- 0.15%
Earnings Market Reaction
- Filing date
- 2026-08-13
- Price on filing date
- —
- 1-month reaction
- 15.09%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 8 | 1 | 9 | 6 | 6 | 4 | 6 | 7 | 7 | 10 | 13 | 16 | ||||||
| Short Term Investments | 4 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Prepaid Expense And Other Assets Current | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | ||||||
| Assets Current | - | 2 | 9 | 6 | 6 | 5 | 7 | 8 | 7 | 10 | 14 | 17 | ||||||
Assets Noncurrent | ||||||||||||||||||
| Property Plant And Equipment Net | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Operating Lease Right Of Use Asset | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Assets Noncurrent | - | - | - | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Assets Noncurrent | - | - | - | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Assets | 12 | - | 9 | 7 | 7 | 5 | 7 | 8 | 8 | 11 | 15 | 18 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Accounts Payable And Other Accrued Liabilities Current | 1 | 1 | 6 | 2 | 2 | 3 | 3 | 2 | 2 | 1 | 3 | 2 | ||||||
| Operating Lease Liability Current | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Convertible Notes Payable Current | - | - | - | - | 7 | - | - | - | - | - | - | - | ||||||
| Liabilities Current | - | 1 | 6 | 2 | 9 | 3 | 3 | 2 | 2 | 2 | 3 | 2 | ||||||
Liabilities Noncurrent | ||||||||||||||||||
| Operating Lease Liability Noncurrent | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities Noncurrent | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities | 1 | - | - | - | - | - | 3 | 2 | 2 | 2 | 3 | 2 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Value | - | - | 0 | - | - | - | - | - | - | - | - | - | ||||||
| Additional Paid In Capital | 96 | 84 | 84 | 78 | 69 | 68 | 64 | 62 | 59 | 58 | 57 | 57 | ||||||
| Retained Earnings Accumulated Deficit | -86 | -84 | -81 | -73 | -70 | -65 | -60 | -56 | -53 | -49 | -45 | -41 | ||||||
| Stockholders Equity | 11 | 1 | 3 | 5 | -2 | 3 | 4 | 6 | 6 | 9 | 12 | 15 | ||||||
| Liabilities And Stockholders Equity | 12 | 2 | 9 | 7 | 7 | 5 | 7 | 8 | 8 | 11 | 15 | 18 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | ||||||
| Common Stock Shares Authorized | 1,000 | 1,000 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | ||||||
| Common Stock Shares Issued | 133 | 113 | 2 | 2 | 1 | 16 | 0 | 10 | 9 | 9 | 8 | 8 | ||||||
| Shares Outstanding | 133 | 113 | 2 | 2 | 17 | 16 | 0 | 10 | 9 | 9 | 8 | 8 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | - | - | - | 0.01 | - | ||||||
| Preferred Stock Shares Authorized | 5 | 5 | 5 | 5 | 5 | 5 | 5 | - | - | - | 5 | - | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 1 | 0 | 0 | 0 | 0 | - | - | - | 0 | - | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 1 | 0 | 0 | 0 | 0 | - | - | - | 0 | - | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialIndaptus Therapeutics, Inc. (INDP) — SEC Financial Statements & Analysis
Indaptus Therapeutics, Inc. (INDP) is a pharmaceutical preparations company, incorporated in DE. Indaptus Therapeutics, Inc. trades on Nasdaq as: INDP. Indaptus Therapeutics, Inc. (INDP)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13. Based on that filing, Indaptus Therapeutics, Inc. carries a market cap of $348.39M, a P/E ratio of -22.59x, a P/B ratio of 30.63x, an enterprise value of $340.84M, and an EV/EBITDA multiple of -23.07x. On profitability, it posts a Return on Equity (ROE) of -318.04%, a Return on Assets (ROA) of -496.74%, and a Return on Invested Capital (ROIC) of -1186.48%. Per share, it reports EPS of $-0.13, diluted EPS of $-0.13, free cash flow per share of $-0.13, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of -9.07% year-over-year and EPS growth of -99.55% year-over-year. On the balance sheet, it maintains a current ratio of 2.34x, a quick ratio of 1.61x, working capital of $1.25M, a debt-to-equity ratio of 0.75x, a debt ratio of 0.43, free cash flow of $-14.70M (TTM), and net debt of $-7.55M. Figures sourced from SEC EDGAR.
- Market Cap
- $348.39M
- P/E TTM
- -22.59x
- EPS TTM
- $-0.13
- P/B TTM
- 30.63x
- ROE TTM
- -318.04%
- ROA TTM
- -496.74%
- Debt To Equity
- 0.75x
- Free Cash Flow TTM
- $-14.70M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Indaptus Therapeutics, Inc. in?
Indaptus Therapeutics, Inc. (INDP) operates in the Pharmaceutical Preparations industry.
What exchange does INDP trade on?
Indaptus Therapeutics, Inc. (INDP) trades on the Nasdaq.
Where is Indaptus Therapeutics, Inc. incorporated?
Indaptus Therapeutics, Inc. is incorporated in DE.
When was Indaptus Therapeutics, Inc. (INDP)'s most recent SEC filing?
Indaptus Therapeutics, Inc. (INDP)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13.
What is INDP's market cap?
Indaptus Therapeutics, Inc. (INDP) has a market capitalization of $348.39M as of 2026-06-30.
What is INDP's EPS (earnings per share)?
Indaptus Therapeutics, Inc. (INDP)'s trailing twelve month EPS is $-0.13 as of 2026-06-30.
What is INDP's ROE (return on equity)?
Indaptus Therapeutics, Inc. (INDP)'s trailing twelve month Return on Equity (ROE) is -318.04% as of 2026-06-30.
What is INDP's ROA (return on assets)?
Indaptus Therapeutics, Inc. (INDP)'s trailing twelve month Return on Assets (ROA) is -496.74% as of 2026-03-31.
What is INDP's ROIC (return on invested capital)?
Indaptus Therapeutics, Inc. (INDP)'s trailing twelve month Return on Invested Capital (ROIC) is -1186.48% as of 2026-06-30.
What is INDP's EV/EBITDA?
Indaptus Therapeutics, Inc. (INDP)'s trailing twelve month EV/EBITDA is -23.07x as of 2026-06-30.